Owlet Announces FDA 510(k) Submission for Prescription Pediatric Monitor
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/11/2026
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but head for 8% weekly gain on tight supply; US diesel hits record
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Owlet Inc. (OWLT) BabySat FDA Submission Seen as a Catalyst - Cowen
October 6, 2022 1:25 PM EDTCowen analyst Charles Rhyee reiterated an Outperform rating and $5.00 price target on Owlet Inc. (NYSE: OWLT) after the company announced its 510(k) submission for BabySat, a wearable sock using pulse oximetry technology to alert parents when their baby's heart rate/ oxygen saturation level fall... More
